Study Finds Mind-Body Therapies Reduce Anxiety, Depression in College Students

A network meta-analysis published March 19, 2026, pooled 27 randomized trials covering 2,664 college students to measure how well mind-body therapies perform against anxiety, depression, and disrupted sleep, offering some of the broadest comparative evidence yet on these interventions in a campus population.

The analysis examined multiple forms of mind-body therapies, explicitly including mindfulness-based interventions, putting different approaches head-to-head rather than comparing a single modality against a control. That design matters: direct comparisons between MBTs remain rare in the clinical trial literature, which is precisely why network meta-analysis has become the preferred method for synthesizing this kind of evidence. By pooling data across 27 trials, the study was able to assess the relative effects of distinct MBT types on all three outcomes simultaneously.

The college student population sits at a particularly acute intersection of mental health need and access barriers. Anxiety and depression are among the most commonly reported conditions at campus counseling centers, and sleep disruption both worsens and is worsened by both. Mind-body therapies, which carry low risk profiles and can be delivered in group or digital formats, have attracted growing interest from student wellness programs looking for scalable, non-pharmacological options.

The March 19 publication arrives alongside a separate, parallel effort in a very different patient population. The MIRACLE protocol, authored by Yoann Birling, Sarah Nevitt, and Deep Jyoti Bhuyan, is a planned systematic review with individual participant data network meta-analysis targeting cancer patients living with depression, anxiety, or insomnia. Where the college student NMA pooled aggregate trial data, MIRACLE intends to go a step further: collecting raw individual participant data from existing RCTs to isolate only those patients who meet clinical thresholds for psychological disturbance, a distinction the protocol's authors flag as critical given that most trials testing MBTs in cancer care have not specifically enrolled patients with diagnosable psychological symptoms.

MIRACLE is organized around three sub-studies, one each for depression, anxiety, and insomnia, and will use both pairwise and network meta-analyses to assess changes across those outcomes as well as treatment completion rates. The protocol also plans to evaluate dose effects, specifically how the number and frequency of MBT sessions influences outcomes. If mind-body therapies prove effective, the protocol states they could be formally recommended as treatments for cancer patients with psychological symptoms, with findings intended to directly inform clinical decision-making.

Taken together, the two efforts reflect a maturing field: researchers are no longer asking simply whether mindfulness and related practices "work," but which specific approaches work best, for whom, at what dose, and under what conditions of psychological severity.